Quince Therapeutics(QNCX.US)

Last Updated 19:00:00 ET
longbridge loading

Quince Therapeutics | 10-K: FY2025 Revenue: USD 0

Earnings Watch·
US
QNCX
+7.56%
Earnings Watch·
US
QNCX
+7.56%

Quince Therapeutics Announces 1-for-10 Reverse Stock Split

Tip Ranks·
US
IBB
+0.10%
US
PBE
+0.11%
US
BBH
+0.68%
Tip Ranks·
US
IBB
+0.10%
US
PBE
+0.11%
US
BBH
+0.68%

12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga_article·
US
ARKG
+0.04%
US
IBBQ
+0.07%
US
PBE
+0.11%
benzinga_article·
US
ARKG
+0.04%
US
IBBQ
+0.07%
US
PBE
+0.11%

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga_article·
US
IBB
+0.10%
US
ARKG
+0.04%
US
QNCX
+7.56%
benzinga_article·
US
IBB
+0.10%
US
ARKG
+0.04%
US
QNCX
+7.56%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga_article·
US
PFSA
-7.31%
US
KPRX
+0.40%
US
CUPR
-3.21%
benzinga_article·
US
PFSA
-7.31%
US
KPRX
+0.40%
US
CUPR
-3.21%

Quince Therapeutics shares are trading higher after the company announced a settlement of its outstanding obligations under a loan from the European Investment Bank for a payment of $5.5 million.

benzinga_article·
US
BIB
+0.05%
US
SBIO
-1.24%
US
QNCX
+7.56%
benzinga_article·
US
BIB
+0.05%
US
SBIO
-1.24%
US
QNCX
+7.56%
© 2026 Longbridge｜Disclaimer